Enliven Therapeutics, Inc. · NASDAQ:ELVN

Collins Helen Louise sold 5,000 Enliven Therapeutics, Inc. shares (Form 4)

Traded Oct 19, 2026 · Filed Oct 21, 2026

On Oct 19, 2026, Collins Helen Louise (CHIEF MEDICAL OFFICER) sold 5,000 Enliven Therapeutics, Inc. shares at US$38.47 for US$192K under a trading plan, leaving 25,000 shares. Filed Oct 21, 2026 (Form 4).

Sold
5,000 shares
Price
US$38.47
Value
US$192K
Holding after
25,000 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CHIEF MEDICAL OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 19, 2026Common StockOption exercise5,000US$2.4830,000Direct
Oct 19, 2026Common StockSale5,000US$38.4725,000Direct

Source

Download original · View original at SEC

Related